PE20070174A1 - Derivados heterociclicos fusionados como inhibidores de quinasa - Google Patents
Derivados heterociclicos fusionados como inhibidores de quinasaInfo
- Publication number
- PE20070174A1 PE20070174A1 PE2006000775A PE2006000775A PE20070174A1 PE 20070174 A1 PE20070174 A1 PE 20070174A1 PE 2006000775 A PE2006000775 A PE 2006000775A PE 2006000775 A PE2006000775 A PE 2006000775A PE 20070174 A1 PE20070174 A1 PE 20070174A1
- Authority
- PE
- Peru
- Prior art keywords
- phenyl
- pyrrolo
- pyrimidin
- chloro
- urea
- Prior art date
Links
- 229940043355 kinase inhibitor Drugs 0.000 title 1
- 239000003757 phosphotransferase inhibitor Substances 0.000 title 1
- CIUQDSCDWFSTQR-UHFFFAOYSA-N [C]1=CC=CC=C1 Chemical compound [C]1=CC=CC=C1 CIUQDSCDWFSTQR-UHFFFAOYSA-N 0.000 abstract 4
- KAESVJOAVNADME-UHFFFAOYSA-N Pyrrole Chemical compound C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 abstract 3
- 108010053099 Vascular Endothelial Growth Factor Receptor-2 Proteins 0.000 abstract 3
- 108091008605 VEGF receptors Proteins 0.000 abstract 2
- 102000016549 Vascular Endothelial Growth Factor Receptor-2 Human genes 0.000 abstract 2
- 102000009484 Vascular Endothelial Growth Factor Receptors Human genes 0.000 abstract 2
- 102100033177 Vascular endothelial growth factor receptor 2 Human genes 0.000 abstract 2
- 229940124676 vascular endothelial growth factor receptor Drugs 0.000 abstract 2
- KKFDJZZADQONDE-UHFFFAOYSA-N (hydridonitrato)hydroxidocarbon(.) Chemical class O[C]=N KKFDJZZADQONDE-UHFFFAOYSA-N 0.000 abstract 1
- 239000004215 Carbon black (E152) Substances 0.000 abstract 1
- 101000851007 Homo sapiens Vascular endothelial growth factor receptor 2 Proteins 0.000 abstract 1
- 150000007945 N-acyl ureas Chemical class 0.000 abstract 1
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical class C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 abstract 1
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 abstract 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 abstract 1
- 239000004202 carbamide Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 229930195733 hydrocarbon Natural products 0.000 abstract 1
- 150000002430 hydrocarbons Chemical class 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- FDDDEECHVMSUSB-UHFFFAOYSA-N sulfanilamide Chemical compound NC1=CC=C(S(N)(=O)=O)C=C1 FDDDEECHVMSUSB-UHFFFAOYSA-N 0.000 abstract 1
- 229940124530 sulfonamide Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Rheumatology (AREA)
- Oncology (AREA)
- Ophthalmology & Optometry (AREA)
- Pain & Pain Management (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
SE REFIERE A DERIVADOS PIRROLO[3,2-d]PIRIMIDINA Y PIRROLO[3,2-d]PIRIDINA DE FORMULA (I), EN DONDE A ES PIRROL; X ES CH OPCIONALMENTE SUSTITUIDO; Y ES CH OPCIONALMENTE SUSTITUIDO O N; Z ES GRUPO HIDROCARBONADO O HETEROCICLICO AMBOS DIVALENTE Y OPCIONALMENTE SUSTITUIDO; T ES UN ENLACE SIMPLE O ALQUILENO(C1-C3); U ES AMIDO, SULFONAMIDO, UREIDO, CARBAMOILO O TIOUREIDO OPCIONALMENTE SUSTITUIDOS. SON PREFERIDOS: N- {2-CLORO-4-[(5-METIL-5H-PIRROLO[3,2-d]PIRIMIDIN-4-IL)OXI]FENIL}-N'-[3-(TRIFLUOROMETIL)FENIL]UREA, N-{2-CLORO-4-[(5-METIL-5H-PIRROLO[3,2-d]PIRIMIDIN-4-IL)OXI]FENIL}-N'-[3-(TRIFLUOROMETOXI)FENIL]UREA, N-{2-CLORO-4-[(5-METIL-5H-PIRROLO[3,2-d]PIRIMIDIN-4-IL)OXI]FENIL}-N'-[4-(TRIFLUOROMETIL)FENIL]UREA, ENTRE OTROS. TAMBIEN SE REFIERE A UNA COMPOSICION FARMACEUTICA Y UN PROCEDIMIENTO DE PREPARACION. ESTOS COMPUESTOS SON INHIBIDORES DEL RECEPTOR DE FACTOR DE CRECIMIENTO ENDOTELIAL VASCULAR (VEGFR), Y LA SELECTIVIDAD POR EL RECEPTOR DE FACTOR DE CRECIMIENTO ENDOTELIAL VASCULAR 2 (VEGFR2, KDR, Flk-1) Y SON UTILES PARA EL TRATAMIENTO Y PREVENCION DEL CANCER
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2005196866 | 2005-07-05 | ||
| JP2006054102 | 2006-02-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20070174A1 true PE20070174A1 (es) | 2007-03-12 |
Family
ID=37055938
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2006000775A PE20070174A1 (es) | 2005-07-05 | 2006-07-04 | Derivados heterociclicos fusionados como inhibidores de quinasa |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20090137580A1 (es) |
| EP (1) | EP1904498A1 (es) |
| JP (1) | JP2009500295A (es) |
| AR (1) | AR055071A1 (es) |
| PE (1) | PE20070174A1 (es) |
| TW (1) | TW200740820A (es) |
| UY (1) | UY31674A1 (es) |
| WO (1) | WO2007004749A1 (es) |
Families Citing this family (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5148499B2 (ja) | 2005-05-20 | 2013-02-20 | メチルジーン インコーポレイテッド | Ｖｅｇｆ受容体およびｈｇｆ受容体シグナル伝達の阻害剤 |
| ES2332423T3 (es) * | 2005-10-28 | 2010-02-04 | Irm Llc | Compuestos y composiciones como inhibidores de proteina quinasas. |
| TW200730527A (en) * | 2005-12-02 | 2007-08-16 | Takeda Pharmaceuticals Co | Fused heterocyclic compound |
| NZ551796A (en) * | 2006-12-05 | 2009-07-31 | Craig Robert Stuart | Bump-resistant pin tumbler lock |
| EP2099444A4 (en) | 2006-12-14 | 2012-11-07 | Nps Pharma Inc | USE OF D-SERIN DERIVATIVES FOR THE TREATMENT OF ANTIBODIES |
| RU2495044C2 (ru) | 2007-08-29 | 2013-10-10 | Метилджен Инк. | Ингибиторы активности протеинтирозинкиназы |
| WO2009096435A1 (ja) * | 2008-01-29 | 2009-08-06 | Takeda Pharmaceutical Company Limited | 縮合複素環誘導体およびその用途 |
| WO2009109035A1 (en) * | 2008-03-05 | 2009-09-11 | Methylgene Inc. | Inhibitors of protein tyrosine kinase activity |
| US8445509B2 (en) | 2008-05-08 | 2013-05-21 | Takeda Pharmaceutical Company Limited | Fused heterocyclic derivatives and use thereof |
| WO2010108503A1 (en) | 2009-03-24 | 2010-09-30 | Life & Brain Gmbh | Promotion of neuronal integration in neural stem cell grafts |
| US9951008B2 (en) * | 2009-11-03 | 2018-04-24 | University Of Notre Dame Du Lac | Ionic liquids comprising heteraromatic anions |
| US8912184B1 (en) | 2010-03-01 | 2014-12-16 | Alzheimer's Institute Of America, Inc. | Therapeutic and diagnostic methods |
| NZ601788A (en) * | 2010-03-01 | 2014-11-28 | Myrexis Inc | Inhibitors of nicotinamide phosphoribosyltransferase and therapeutic uses thereof |
| JP2013523715A (ja) | 2010-03-31 | 2013-06-17 | アクテリオン ファーマシューティカルズ リミテッド | イソキノリン−３−イル尿素誘導体 |
| WO2012008564A1 (ja) * | 2010-07-16 | 2012-01-19 | 協和発酵キリン株式会社 | 含窒素芳香族複素環誘導体 |
| AR088729A1 (es) | 2011-03-29 | 2014-07-02 | Actelion Pharmaceuticals Ltd | Derivados de 3-ureidoisoquinolin-8-ilo y una composicion farmaceutica |
| BR112014010551A2 (pt) | 2011-10-31 | 2017-05-02 | Glaxosmithkline Ip Dev Ltd | composição adequada para a reconstituição em uma suspensão aquosa, pó para a combinação direta para o uso em composição farmacêutica, formulação farmacêutica de suspensão oral, e, suspensão oral |
| EP2981526B1 (en) | 2013-04-02 | 2021-11-03 | Oxular Acquisitions Limited | Intermediates useful in the preparation of naphthylurea derivatives useful as kinase inhibitors |
| MX367085B (es) | 2013-07-31 | 2019-08-05 | Merck Patent Gmbh | Piridinas, pirimidinas y pirazinas como inhibidores de tirosina cinasa de bruton e inhibidores y usos de las mismas. |
| WO2015048765A1 (en) | 2013-09-30 | 2015-04-02 | University Of Notre Dame Du Lac | Compounds, complexes, compositions, methods and systems for heating and cooling |
| WO2015069799A1 (en) | 2013-11-05 | 2015-05-14 | University Of Notre Dame Du Lac | Carbon dioxide capture using phase change ionic liquids |
| US9890185B2 (en) | 2013-12-20 | 2018-02-13 | Respivert Limited | Urea derivatives useful as kinase inhibitors |
| MA40774A (fr) | 2014-10-01 | 2017-08-08 | Respivert Ltd | Dérivés de diaryle-urée en tant qu'inhibiteurs de kinase p38 |
| CA2991697A1 (en) | 2015-08-31 | 2017-03-09 | Toray Industries, Inc. | Urea derivative and use therefor |
| AU2017245888B2 (en) | 2016-04-06 | 2021-05-13 | Oxular Acquisitions Limited | Kinase inhibitors |
| EP3503888A4 (en) * | 2016-08-25 | 2020-02-26 | The Regents of The University of Michigan | BCR-ABL MUTANT INHIBITORS AND THEIR USE |
| CN109180677A (zh) * | 2017-06-30 | 2019-01-11 | 厦门大学 | 取代芳基醚类化合物、其制备方法、药用组合物及其应用 |
| KR20210142154A (ko) | 2019-03-21 | 2021-11-24 | 옹쎄오 | 암 치료를 위한 키나제 억제제와 조합된 dbait 분자 |
| CN110128299B (zh) * | 2019-05-13 | 2020-11-10 | 浙江大学 | 一种二苯基脲类抗肿瘤小分子抑制剂及其制备方法 |
| US20220229072A1 (en) | 2019-06-04 | 2022-07-21 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Use of cd9 as a biomarker and as a biotarget in glomerulonephritis or glomerulosclerosis |
| WO2021089791A1 (en) | 2019-11-08 | 2021-05-14 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods for the treatment of cancers that have acquired resistance to kinase inhibitors |
| WO2021148581A1 (en) | 2020-01-22 | 2021-07-29 | Onxeo | Novel dbait molecule and its use |
| CN116789670A (zh) * | 2022-03-17 | 2023-09-22 | 中国科学院合肥物质科学研究院 | 一种选择性csf1r抑制剂及其用途 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL112249A (en) * | 1994-01-25 | 2001-11-25 | Warner Lambert Co | Pharmaceutical compositions containing di and tricyclic pyrimidine derivatives for inhibiting tyrosine kinases of the epidermal growth factor receptor family and some new such compounds |
| AR004010A1 (es) * | 1995-10-11 | 1998-09-30 | Glaxo Group Ltd | Compuestos heterociclicos |
| CA2260058A1 (en) * | 1996-07-13 | 1998-01-22 | Kathryn Jane Smith | Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors |
| AU735401B2 (en) | 1996-08-28 | 2001-07-05 | Pfizer Inc. | Substituted 6,5-hetero-bicyclic derivatives |
| EP1384712B1 (en) * | 1999-01-22 | 2007-03-07 | Kirin Beer Kabushiki Kaisha | Derivatives of N-((quinolinyl)oxy)-phenyl)-urea and N-((quinazolinyl)oxy)-phenyl)-urea with antitumor activity |
| CA2407593C (en) | 2000-04-27 | 2011-01-11 | Yamanouchi Pharmaceutical Co. Ltd. | Fused heteroaryl derivatives |
| KR100589032B1 (ko) * | 2000-10-20 | 2006-06-14 | 에자이 가부시키가이샤 | 질소 함유 방향환 유도체 |
| DK1382604T3 (da) * | 2001-04-27 | 2006-04-18 | Kirin Brewery | Quinolinderivater med en azolylgruppe og quinazolinderivater |
| GEP20105024B (en) * | 2004-06-02 | 2010-06-25 | Takeda Pharmaceuticals Co | Fused heterocyclic compound |
-
2006
- 2006-07-03 TW TW095124128A patent/TW200740820A/zh unknown
- 2006-07-04 PE PE2006000775A patent/PE20070174A1/es not_active Application Discontinuation
- 2006-07-05 AR ARP060102891A patent/AR055071A1/es not_active Application Discontinuation
- 2006-07-05 EP EP06780985A patent/EP1904498A1/en not_active Withdrawn
- 2006-07-05 WO PCT/JP2006/313815 patent/WO2007004749A1/en active Application Filing
- 2006-07-05 JP JP2007556190A patent/JP2009500295A/ja not_active Withdrawn
- 2006-07-05 US US11/922,310 patent/US20090137580A1/en not_active Abandoned
-
2009
- 2009-02-25 UY UY031674A patent/UY31674A1/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| UY31674A1 (es) | 2009-08-31 |
| JP2009500295A (ja) | 2009-01-08 |
| EP1904498A1 (en) | 2008-04-02 |
| AR055071A1 (es) | 2007-08-01 |
| TW200740820A (en) | 2007-11-01 |
| WO2007004749A1 (en) | 2007-01-11 |
| US20090137580A1 (en) | 2009-05-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20070174A1 (es) | Derivados heterociclicos fusionados como inhibidores de quinasa | |
| RU2538200C2 (ru) | ПИРИМИДИНОВЫЕ СОЕДИНЕНИЯ (ВАРИАНТЫ), СПОСОБ ИХ ПОЛУЧЕНИЯ, КОМПОЗИЦИЯ ИХ СОДЕРЖАЩАЯ И СПОСОБ ЛЕЧЕНИЯ ЗАБОЛЕВАНИЙ, СВЯЗАННЫХ С КИНАЗОЙ mTOR ИЛИ КИНАЗОЙ PI3K | |
| ES2344347T3 (es) | Derivados de cianopiridina novedosos utiles en el tratamiento de cancer y otros trastornos. | |
| PE20080538A1 (es) | Derivado heterociclico fusionado y su uso | |
| PE20121127A1 (es) | Derivados de piridina y pirazina como moduladores de cinasa de proteina | |
| CA2900308C (en) | Substituted bicyclic dihydropyrimidinones and their use as inhibitors of neutrophil elastase activity | |
| PE20040189A1 (es) | Pirimidina y piridina biciclicos como inhibidores de p38 quinasa | |
| AR079231A1 (es) | Derivados de imidazoquinolina | |
| RU2505534C2 (ru) | Производные хиназолина, ингибирующие активность egfr | |
| PE20170677A1 (es) | Nuevos compuestos como inhibidores de reorganizado durante la transfeccion (ret) | |
| PE20060932A1 (es) | Derivados de sulfonamidas como moduladores de receptores de glucocorticoides (gr) | |
| PE20061067A1 (es) | Derivados de pirimidina | |
| RU2012143689A (ru) | Спироциклические соединения и их применение в качестве терапевтических агентов и диагностических зондов | |
| PE20100087A1 (es) | Compuestos y composiciones como inhibidores de cinasa | |
| AR054799A1 (es) | Derivados de oxindol | |
| AR058403A1 (es) | PIRIMIDINILOXI Y PIRIDINILOXI UREAS SUSTITUíDAS COMO INHIBIDORES DE PROTEíNA QUINASAS, COMPOSICIONES FARMACÉUTICAS QUE LAS CONTIENEN Y SU USO EN LA PREPARACIoN DE UN MEDICAMENTO PARA EL TRATAMIENTO DE ENFERMEDADES MEDIADAS POR LA ACTIVIDAD BASAL DE B-RAF. | |
| AR074426A1 (es) | Compuesto de n-(((1s,4s,6s)-3-(2-piridinilcarbonil)3-azabiciclo (4,1.0)hept-4-il) metil)-2-heteroarilamina, su uso para la prepracion de un medicamento para el tratamiento de una enfermedad que requiere un antagonista de un receptor de orexina humana y composicion farmaceutica que lo comprende | |
| NO20083822L (no) | Farmasoytisk antikreftpreparat | |
| AR054360A1 (es) | Derivados de tiazol como herbicidas | |
| PE20070855A1 (es) | Derivados de 4-amino-pirrolotriazina sustituida como inhibidores de quinasas | |
| PE20051046A1 (es) | Derivados de diaril-urea en el tratamiento de enfermedades dependientes de la quinasa de proteina | |
| AR052357A1 (es) | Pirazolo piridinas sustituidas moduladoras de la actividad de quinasas | |
| RU2013109132A (ru) | Химические соединения | |
| PE20091656A1 (es) | Compuestos heterociclicos como inhibidores de la cinasa raf | |
| RU2007148217A (ru) | Получение производных n-фенил-2-пиримидинамина |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |